Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

Ductal carcinoma in situ (DCIS) is an often-diagnosed breast disease and a known, non-obligate, precursor to invasive breast carcinoma. In this review, we explore the clinical and pathological features of DCIS, fundamental elements of DCIS biology including gene expression and genetic events, the re...

Full description

Bibliographic Details
Main Authors:	Kylie L. Gorringe, Stephen B. Fox
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Oncology
Subjects:	ductal carcinoma in situ invasive breast cancer progression recurrence biomarkers microenvironment
Online Access:	http://journal.frontiersin.org/article/10.3389/fonc.2017.00248/full

Similar Items

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
by: Tanjina Kader, et al.
Published: (2018-05-01)

Different distribution of breast ductal carcinoma <it>in situ</it>, ductal carcinoma <it>in situ</it> with microinvasion, and invasion breast cancer
by: Wei Zhang, et al.
Published: (2012-12-01)

The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ
by: Ga Young Yoon, et al.
Published: (2020-08-01)

Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women
by: Hyeonyoung Ko, et al.
Published: (2017-12-01)

Clinicopathological features and prognostic differences of ductal carcinoma in situ with ductal carcinoma in situ with microinvasion
by: LIU Jing, et al.
Published: (2020-07-01)

Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis
by: Wu SG, et al.
Published: (2018-03-01)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
by: Koji Takada, et al.
Published: (2020-06-01)

Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective
by: Wai Peng Lee, et al.
Published: (2022-09-01)

Potential biomarkers of ductal carcinoma in situ progression
by: Raquel Spinassé Dettogni, et al.
Published: (2020-02-01)

MICROINVASIVE IN SITU DUCTAL BREAST CARCINOMA IN MAN
by: Adem Karataş, et al.
Published: (2009-07-01)

Surgical margin and local recurrence of ductal carcinoma in situ
by: Michael Co, et al.
Published: (2024-01-01)

Does a Close Surgical Margin for Ductal Carcinoma In Situ Associated with Invasive Breast Carcinoma Affect Breast Cancer Recurrence?
by: Bekir Kuru, et al.
Published: (2020-08-01)

Ductal carcinoma in situ: a challenging disease
by: Sevilay Altintas, et al.
Published: (2011-12-01)

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
by: Kwan Ho Lee, et al.
Published: (2019-12-01)

Long Term Clinical Outcome and Prognostic Factors after Treatment of Patients Diagnosed with Ductal Carcinoma in Situ of Breast
by: Ativitch AsavachaIsuvikom, et al.
Published: (2022-08-01)

Low-Grade and High-Grade Invasive Ductal Carcinomas of the Breast Follow Divergent routes of Progression
by: Yun NIU, et al.
Published: (2011-09-01)

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
by: Marie Beguinot, et al.
Published: (2018-02-01)

Ductal carcinoma in situ of the breast
by: Jennifer L. Peterson, et al.
Published: (2011-12-01)

Establishment of a 3D co‐culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast
by: Marina Sourouni, et al.
Published: (2023-04-01)

A single-center prognotic analysis of breast ductal carcinoma in situ
by: YANG Yilan, ZHAO Xu, CHEN Xingxing, WANG Xuanyi, JIN Kairui, ZHANG Zhen, SHAO Zhimin, GUO Xiaomao, YU Xiaoli
Published: (2022-03-01)

An insight into the invasion of breast ductal carcinoma in situ based on clinical, pathological and hematological data
by: Yanbiao Liu, et al.
Published: (2022-08-01)

P-cadherin and CD10 Expression to Distinguish between Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
by: Kanet Kanjanapradit, et al.
Published: (2019-02-01)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
by: Sheng-Kai Hsu, et al.
Published: (2023-03-01)

Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
by: Libo Yang, et al.
Published: (2022-08-01)

Variação interobservador no diagnóstico histopatológico do carcinoma ductal in situ da mama Interobserver variation of the histopathologic diagnosis of ductal carcinoma in situ of the breast
by: Márcio de Almeida Salles, et al.
Published: (2005-01-01)

Machine Learning Algorithm for Distinguishing Ductal Carcinoma In Situ from Invasive Breast Cancer
by: Vu Pham Thao Vy, et al.
Published: (2022-05-01)

Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
by: Jiao Zhang, et al.
Published: (2023-02-01)

Impact of consensus guidelines for breast‐conserving surgery in patients with ductal carcinoma in situ
by: Abigail Tremelling, et al.
Published: (2022-05-01)

Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma
by: A.F. Logullo, et al.
Published: (2002-08-01)

Neoductgenesis in Ductal Carcinoma In Situ Coexists with Morphological Abnormalities Characteristic for More Aggressive Tumor Biology
by: Agnieszka Łazarczyk, et al.
Published: (2023-02-01)

A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
by: Luca Nicosia, et al.
Published: (2022-01-01)

Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity
by: Saida Sakhri, et al.
Published: (2020-01-01)

Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast
by: Lovely George, et al.
Published: (2018-04-01)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
by: Zhou Huang, et al.
Published: (2023-09-01)

Breast ductal carcinoma in situ: a literature review of adjuvant hormonal therapy
by: Stephen Kinsey-Trotman, et al.
Published: (2016-12-01)

Does Existence of Ductal Carcinoma In Situ Accompanying Invasive Ductal Carcinoma Lead to Different Clinicopathological Features and Clinical Outcome? Report of a Breast Cancer Registry
by: Sedigheh Tahmasebi, et al.
Published: (2022-07-01)

Multiple Microinvasion Foci in Ductal Carcinoma In Situ Is Associated With an Increased Risk of Recurrence and Worse Survival Outcome
by: Jing Si, et al.
Published: (2020-12-01)

Ductal carcinoma in situ (DCIS) presenting as a cystic retroareolar lesion in an African American man
by: Amara Ndumele, et al.
Published: (2021-06-01)

The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer
by: Emma Grundtvig Gram, et al.
Published: (2023-08-01)

Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization
by: Irina V. Kolyadina, et al.
Published: (2021-08-01)